Search bioRxiv⌕ Search

Biology subjects

Kalisky, T.

Publications and source records attributed to Kalisky, T..

12 recordsLinked to original sources

Robustness measures for cell type classification in single-cell RNA-seq datasets of kidney organoids

Background: Induced pluripotent stem cell (iPSC)-derived kidney organoids hold great promise for disease modeling, drug screening, and regenerative medicine. However, since these organoids are synthetic constructs, it is essential to evaluate how faithfully their constituent cell populations recapitulate the corresponding cell types in the native kidney. Single-cell transcriptomic label-transfer tools, which assign cell-type labels by integrating cells with well-annotated reference data and classifying them, are increasingly used for this purpose. Yet the reliability of the resulting labels - particularly for immature or partially differentiated cells that might have no clear in vivo counterpart - has not been systematically addressed. Methodology: To quantify the reliability of cell-type labels assigned by label-transfer algorithms, we introduce two complementary robustness measures for each cell type - the classification stability score, which assesses label stability under simulated Poisson noise, and the prediction specificity score, which assesses how well the predicted cell-type label probabilities match the assigned labels. We apply this methodology to scRNA-seq datasets from the human fetal kidney and four iPSC-derived kidney organoid protocols, using a mouse fetal kidney dataset as a reference. Results: We find that label-transfer robustness scores are generally high in most human fetal kidney cell types, except for cells of immature epithelial structures. In the organoid-derived cell subpopulations, robustness scores are high for the cap mesenchyme but vary for epithelial lineages according to each protocol's specific differentiation strategy. These observations are consistent across both classification stability and prediction specificity scores, which are generally well correlated with each other. We further validate our approach through a simulated cell-removal experiment, confirming that the proposed measures correctly identify unreliable classifications. Significance: These robustness measures provide a generalizable framework for assessing the reliability of cell-type label transfer in single-cell transcriptomic datasets, and can be extended to other biomedical settings that rely on automated single-cell classification.

genomics↗

Characterizing Gene Regulatory Network Ensembles in Kidney Injury and Repair

The inference of gene regulatory networks (GRNs) from single-cell RNAseq data allows for mechanistic characterization of the different cell states and their dynamics in complex biological processes. While numerous algorithms have been proposed to infer GRNs from single-cell transcriptomic data, multiple network solutions may explain the same dataset, posing a challenge for biologically meaningful interpretation. Here, we use the Reasoning Engine for Interaction Networks (RE:IN), a computational tool based on formal reasoning, to characterize GRN ensembles in the context of acute kidney injury (AKI). To this end, we applied RE:IN to a single-cell RNAseq dataset from a mouse ischemiareperfusion injury (IRI) model, focusing on distinct proximal tubule cell states related to kidney injury and repair. We first created an Abstract Boolean Net-work (ABN) model for the kidney using RE:IN and synthesized an ensemble of consistent network solutions. Then, we visualized the ensemble in latent space using Principal Components Analysis (PCA) and discovered four distinct GRN families compatible with the input gene expression and regulatory constraints. Finally, we identified two specific network substructures that discern between the four different network families. This study provides a methodology for characterizing and interpreting GRN heterogeneity in complex processes such as tissue development, disease, and repair.

systems biology↗

Dynamics of cell states and alternative splicing following kidney ischemia-reperfusion injury

The progression of kidney damage in chronic kidney disease (CKD) involves multiple post-injury stages and complex cellular and molecular mechanisms that are not yet fully understood. In our study we set to characterize the dynamics of mRNA splicing following kidney injury. To this end, we analyzed publicly available bulk RNA-seq data covering nine time points following a kidney ischemia-reperfusion injury (IRI) mouse experiment. Using topic modeling we discerned five distinct temporal phases corresponding to the following cell states: "early injury response", "injury", "repairing", "failed recovery", and "healthy proximal tubule". Additionally, we discovered a set of genes that are alternatively spliced between selected time points associated with these cell states, some of which are related to injury, stress, EMT, and apoptosis. Finally, we found several putative splicing regulators that are differentially expressed between the different time points and whose binding motifs are enriched in the vicinity of alternatively spliced exons, indicating that they may play critical roles in mRNA splicing dynamics following kidney injury and repair. These findings enhance our understanding of the molecular mechanisms involved in kidney injury and repair, offering potential avenues for developing targeted therapeutic strategies for acute kidney injury (AKI) and its progression to CKD.

genomics↗

Characterization of alternative mRNA splicing associated with tumor thrombus in clear-cell renal cell carcinoma

Approximately 10% of Renal Cell Carcinoma (RCC) tumors form a thrombus that invades into nearby vasculature and is associated with lower survivability. However, the mechanisms driving tumor thrombus formation and progression are poorly understood. We therefore examined a publicly available RNAseq dataset of samples from RCC patients containing tumors with and without thrombi, as well as associated normal kidney tissues, and compared them. Using cell deconvolution, we found indications that kidney tumors and thrombi are associated with loss of mature kidney-specific cell types and gain of proliferative characteristics. Moreover, we identified a set of transcripts that are alternatively spliced between tumors with and without thrombi. Using motif enrichment analysis for known RNA binding proteins we found putative splicing regulators that are presumably associated with thrombus formation. We believe that this study will assist in unraveling cellular and molecular mechanisms of tumor progression and thrombus formation in RCC.

cancer biology↗

Characterization of alternative splicing in high-risk Wilms tumors

The significant heterogeneity of Wilms tumors between different patients is thought to arise from genetic and epigenetic distortions that occur during various stages of fetal kidney development in a way that is poorly understood. To address this, we characterized the heterogeneity of alternative mRNA splicing in Wilms tumors using a publicly available RNAseq dataset of high-risk Wilms tumors and normal kidney samples. Through Pareto task inference and cell deconvolution, we found that the tumors and normal kidney samples are organized according to progressive stages of kidney development within a triangle-shaped region in latent space, whose vertices, or "archetypes," resemble the cap mesenchyme, the nephrogenic stroma, and epithelial tubular structures of the fetal kidney. We identified a set of genes that are alternatively spliced between tumors located in different regions of latent space and found that many of these genes are associated with the Epithelial to Mesenchymal Transition (EMT) and muscle development. Using motif enrichment analysis, we identified putative splicing regulators, some of which are associated with kidney development. Our findings provide new insights into the etiology of Wilms tumors and suggest that specific splicing mechanisms in early stages of development may contribute to tumor development in different patients.

cancer biology↗

Uncovering cellular processes in HeLa cells using unsupervised machine learning

Gene expression measurements of tissues, tumors, or cell lines taken over multiple time points are valuable for describing dynamic biological phenomena such as the response to growth factors. However, such phenomena typically involve multiple biological processes occurring in parallel, making it difficult to identify and discern their respective contributions at any time point. Here, we demonstrate the use of unsupervised machine learning to deconvolve a series of time-dependent gene expression measurements into its underlying temporal components. We first downloaded publicly available RNAseq data obtained from synchronized HeLa cells at consecutive time points following release from cell cycle arrest. Then, we used Fourier analysis and Topic modeling to reveal three underlying components and their relative contributions at each time point. We identified two temporal components with oscillatory behavior, corresponding to the G1-S and G2-M phases of the cell cycle, and a third component with a transient expression pattern, associated with the immediate-early response gene program, regulation of cell proliferation, and cervical cancer. This study demonstrates the use of unsupervised machine learning to identify hidden temporal components in biological systems, with potential applications to early detection and monitoring of diseases and recovery processes.

genomics↗

Characterization of the continuous transcriptional heterogeneity in Wilms tumors using unsupervised machine learning

Wilms tumors are pediatric malignancies that are thought to arise from faulty kidney development. To date, the course of treatment depends on manual histopathological classification which is difficult since the tumors differ between patients in a continuous manner. Here, we used three computational approaches to characterize the continuous heterogeneity of Wilms tumors. We first chose a published dataset of microarray gene expression measurements from high-risk blastemal-type Wilms tumors. Then, we used Pareto Task Inference to show that the tumors form a triangle-shaped continuum in latent space that is bounded by three tumor archetypes with "stromal", "epithelial", and "blastemal" characteristics, that resemble the un-induced mesenchyme, the Cap mesenchyme, and early epithelial structures of the fetal kidney. We confirmed this by fitting a generative probabilistic "grade of membership" model whereby each tumor is represented as a unique mixture of three hidden "topics" with blastemal, stromal, and epithelial characteristics. Finally, we used cellular deconvolution to show that each tumor is composed of a unique mixture of cell populations resembling the un-induced mesenchyme, the cap mesenchyme, and the early epithelial structures of the fetal kidney. We anticipate that these methodologies will pave the way for more quantitative strategies for tumor stratification and classification.

cancer biology↗

Molecular characterization of clonal human renal forming cells

The adult kidney replaces its parenchyma in vivo in steady state and during regeneration by segment-specific clonal cell proliferation. To understand human adult kidney clonal cell growth, we derived tissue from human nephrectomies and performed limiting dilution to establish genuine clonal cultures from one single cell. Clonal efficiency of the human kidney was x%. Remarkably, a single renal cell could give rise to up to 3.3*10(6) cells. Phenotypically, two types of clonal cultures were apparent; a stably proliferating cuboidal epithelial-like appearing (EL) and a rapidly proliferating fibroblast-like appearing (FL). RNA sequencing of all clonal cultures separated FL from EL cultures according to proximal-distal/collecting renal epithelial tubular identity, respectively. Moreover, distinct molecular features in respect to cell-cycle, epithelial-mesenchymal transition, oxidative phosphorylation, BMP signaling pathway and cell surface markers were observed for each clone type. Surprisingly, clonal expansion (>3 months) was sustained in EL clones harboring markers of mature kidney epithelia (high CD24, CDH1, EpCAM, EMA) in contrast to de-differentiated FL clones (high NCAM1, serpine1), which showed fast lineage amplification and exhausted in a few weeks. Thus, the human adult kidney harbors progenitor cell function in which segment identity and the level of epithelial differentiation dictate clonal characteristics.

cell biology↗

Characterization of splice isoform switching during human kidney development

Nephrons are the functional units of the kidney. During kidney development, cells from the cap mesenchyme - a transient kidney-specific progenitor state - undergo a mesenchymal to epithelial transition (MET) and subsequently differentiate into the various epithelial cell types that create the tubular structures of the nephron. Faults in this transition can lead to a pediatric malignancy of the kidney called Wilms tumor that mimics normal kidney development. While kidney development has been characterized at the gene expression level, a comprehensive characterization of alternative splicing is lacking. We therefore performed RNA sequencing on cell populations representing early, intermediate, and late developmental stages of the human fetal kidney, as well as three blastemal-predominant Wilms tumor patient-derived xenografts. We identified a set of transcripts that are alternatively spliced between the different developmental stages. Moreover, we found that cells from the earliest developmental stage have a mesenchymal splice-isoform profile that is similar to that of blastemal-predominant Wilms tumors. RNA binding motif enrichment analysis suggests that the mRNA binding proteins ESRP1, ESRP2, RBFOX2, and QKI regulate mRNA splice isoform switching during human kidney development. These findings illuminate new molecular mechanisms involved in kidney development and pediatric kidney tumors.\n\nHIGHLIGHTSO_LIDuring fetal kidney development, kidney progenitor cells undergo a mesenchymal to epithelial transition (MET) and subsequently differentiate into the various epithelial cell types that create the tubular structures of the nephron.\nC_LIO_LIRNA sequencing identifies a set of transcripts that undergo splice isoform switching during the mesenchymal to epithelial transition (MET) that occurs in the course of human fetal kidney development.\nC_LIO_LICells in the early stages of kidney development have a mesenchymal splice-isoform profile that is similar to that observed in blastemal-predominant Wilms tumor patient-derived xenografts (WT-PDX) that represent an aggressive subtype of Wilms tumors.\nC_LIO_LIRNA binding motif enrichment analysis indicates that the mRNA binding proteins ESRP1, ESRP2, RBFOX2, and QKI regulate splice isoform switching during human kidney development.\nC_LI

genomics↗

Single-cell RNA sequencing reveals mRNA splice isoform switching during kidney development

During mammalian kidney development, nephron progenitors undergo a mesenchymal to epithelial transition and eventually differentiate into the various tubular segments of the nephron. Recently, the different cell types in the developing kidney were characterized using the Dropseq single cell RNA sequencing technology for measuring gene expression from thousands of individual cells. However, many genes can also be alternatively spliced and this creates an additional layer of heterogeneity. We therefore used full transcript length single-cell RNA sequencing to obtain the transcriptomes of 544 individual cells from mouse embryonic kidneys. We first used gene expression levels to identify each cell type. Then, we comprehensively characterized the splice isoform switching that occurs during the transition between mesenchymal and epithelial cellular states and identified several putative splicing regulators, including the genes Esrp1/2 and Rbfox1/2. We anticipate that these results will improve our understanding of the molecular mechanisms involved in kidney development.

genomics↗

Applications of community detection algorithms to large biological datasets

Recent advances in data acquiring technologies in biology have led to major challenges in mining relevant information from large datasets. For example, single-cell RNA sequencing technologies are producing expression and sequence information from tens of thousands of cells in every single experiment. A common task in analyzing biological data is to cluster samples or features (e.g. genes) into groups sharing common characteristics. This is an NP-hard problem for which numerous heuristic algorithms have been developed. However, in many cases, the clusters created by these algorithms do not reflect biological reality. To overcome this, a Networks Based Clustering (NBC) approach was recently proposed, by which the samples or genes in the dataset are first mapped to a network and then community detection (CD) algorithms are used to identify clusters of nodes. Here, we created an open and flexible python-based toolkit for NBC that enables easy and accessible network construction and community detection. We then tested the applicability of NBC for identifying clusters of cells or genes from previously published large-scale single-cell and bulk RNA-seq datasets. We show that NBC can be used to accurately and efficiently analyze large-scale datasets of RNA sequencing experiments.

bioinformatics↗

CDK19 is a Regulator of Triple-Negative Breast Cancer Growth

Triple-negative breast cancer (TNBC) is a poor prognosis disease with no clinically approved targeted therapies. Here, using in vitro and in vivo RNA interference (RNAi) screens in TNBC patient-derived xenografts (PDX), we identify cyclin dependent kinase 19 (CDK19) as a potential therapeutic target. Using in vitro and in vivo TNBC PDX models, we validated the inhibitory effect of CDK19 knockdown on tumor initiation, proliferation and metastases. Despite this, CDK19 knockdown did not affect the growth of non-transformed mammary epithelial cells. Using CD10 and EpCAM as novel tumor initiating cell (TIC) markers, we found the EpCAMmed/high/CD10-/low TIC sub-population to be enriched in CDK19 and a putative cellular target of CDK19 inhibition. Comparative gene expression analysis of CDK19 and CDK8 knockdowns revealed that CDK19 regulates a number of cancer-relevant pathways, uniquely through its own action and others in common with CDK8. Furthermore, although it is known that CDK19 can act at enhancers, our CHIP-Seq studies showed that CDK19 can also epigenetically modulate specific H3K27Ac enhancer signals which correlate with gene expression changes. Finally, to assess the potential therapeutic utility of CDK19, we showed that both CDK19 knockdown and chemical inhibition of CDK19 kinase activity impaired the growth of pre-established PDX tumors in vivo. Current strategies inhibiting transcriptional co-factors and targeting TICs have been limited by toxicity to normal cells. Because of CDK19s limited tissue distribution and the viability of CDK19 knockout mice, CDK19 represents a promising therapeutic target for TNBC.

cancer biology↗